{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:36:34Z","timestamp":1787938594115,"version":"build-2784847793"},"reference-count":99,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"De Speekerkes vzw"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Duchenne muscular dystrophy (DMD), the severest form of muscular dystrophy, is characterized by progressive muscle weakness with fatal outcomes most often before the fourth decade of life. Despite the recent addition of molecular treatments, DMD remains a disease without a cure, and the need persists for the development of supportive therapies aiming to help improve patients\u2019 quality of life. This review focuses on the therapeutical potential of amino acid and derivative supplements, summarizing results obtained in preclinical studies in murine disease models. Several promising compounds have emerged, with L-arginine, N-acetylcysteine, and taurine featuring among the most intensively investigated. Their beneficial effects include reduced inflammatory, oxidative, fibrotic, and necrotic damage to skeletal muscle tissues. Improvement of muscle strength and endurance have been reported; however, mild side effects have also surfaced. More explorative, placebo-controlled and long-term clinical trials would need to be conducted in order to identify amino acid formulae that are safe and of true benefit to DMD patients.<\/jats:p>","DOI":"10.3390\/biomedicines11072033","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T21:21:46Z","timestamp":1689801706000},"page":"2033","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["What Nutraceuticals Can Do for Duchenne Muscular Dystrophy: Lessons Learned from Amino Acid Supplementation in Mouse Models"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9403-4401","authenticated-orcid":false,"given":"Boel","family":"De Paepe","sequence":"first","affiliation":[{"name":"Department of Neurology, Ghent University & Neuromuscular Reference Center, Ghent University Hospital, Route 830, Corneel Heymanslaan 10, 9000 Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13023-021-01862-w","article-title":"The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: A systematic literature review","volume":"16","author":"Szabo","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1186\/s13023-021-01758-9","article-title":"Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?","volume":"16","author":"Kourakis","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fgene.2018.00114","article-title":"Combined therapies for Duchenne muscular dystrophy to optimize treatment efficacy","volume":"9","author":"Cordova","year":"2018","journal-title":"Front. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nbd.2008.03.008","article-title":"Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy","volume":"31","author":"Grounds","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/0884533615586202","article-title":"Nutrition considerations in Duchenne muscular dystrophy","volume":"30","author":"Davis","year":"2015","journal-title":"Nutr. Clin. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Childers, M. (2016). Regenerative Medicine for Degenerative Muscle Diseases, Humana Press. Stem Cell Biology and Regenerative Medicine.","DOI":"10.1007\/978-1-4939-3228-3"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"928385","DOI":"10.1155\/2015\/928385","article-title":"Optimizing bone health in Duchenne muscular dystrophy","volume":"2015","author":"Buckner","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Woodman, K.G., Coles, C.A., Lamand\u00e9, S.R., and White, J.D. (2016). Nutraceuticals and their potential to treat Duchenne muscular dystrophy: Separating the Credible from the Conjecture. Nutrients, 8.","DOI":"10.3390\/nu8110713"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"104917","DOI":"10.1016\/j.phrs.2020.104917","article-title":"Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: Considerations for Standard of Care and emerging virus outbreaks","volume":"158","author":"Boccanegra","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/ajcn\/86.4.1120","article-title":"Cysteine: A conditionally essential amino acid in low-birth-weight preterm infants?","volume":"86","author":"Riedijk","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Terrill, J.R., Huchet, C., Le Guiner, C., Lafoux, A., Caudal, D., Tulangekar, A., Bryson-Richardson, R.J., Sztal, T.E., Grounds, M.D., and Arthur, P.G. (2023). Muscle pathology in dystrophic rats and zebrafish is unresponsive to taurine treatment, compared to the mdx mouse model for Duchenne muscular dystrophy. Metabolites, 13.","DOI":"10.3390\/metabo13020232"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.mri.2012.04.003","article-title":"Metabolic profile of dystrophic mdx mouse muscles analyzed with in vitro magnetic resonance spectroscopy (MRS)","volume":"30","author":"Bloise","year":"2012","journal-title":"Magn. Reson. Imag."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"102040","DOI":"10.1016\/j.redox.2021.102040","article-title":"Duchenne\u2019s muscular dystrophy involves a defective transsulfuration pathway activity","volume":"45","author":"Panza","year":"2021","journal-title":"Redox Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.biocel.2015.07.016","article-title":"Taurine deficiency, synthesis and transport in the mdx mouse model for Duchenne Muscular Dystrophy","volume":"66","author":"Terrill","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/nu2010075","article-title":"Effects of beta-alanine on muscle carnosine and exercise performance: A review of the current literature","volume":"2","author":"Culbertson","year":"2010","journal-title":"Nutrients"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","article-title":"Regulation of glutathione synthesis","volume":"30","author":"Lu","year":"2009","journal-title":"Mol. Asp. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1179\/1351000214Y.0000000112","article-title":"Effect of N-acetylcysteine plus deferoxamine on oxidative stress and inflammation in dystrophic muscle cells","volume":"20","author":"Marques","year":"2015","journal-title":"Redox Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1152\/japplphysiol.00371.2004","article-title":"N-acetylcysteine enhances muscle cysteine and glutathione availability and attenuates fatigue during prolonged exercise in endurance-trained individuals","volume":"97","author":"Medved","year":"2004","journal-title":"J. Appl. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Merckx, C., and De Paepe, B. (2022). The role of taurine in skeletal muscle functioning and its potential as a supportive treatment for Duchenne muscular dystrophy. Metabolites, 12.","DOI":"10.3390\/metabo12020193"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1550-2783-7-27","article-title":"Ergogenic effects of betaine supplementation on strength and power performance","volume":"7","author":"Lee","year":"2010","journal-title":"J. Int. Soc. Sports Nutr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10545-010-9088-4","article-title":"Choline and betaine in health and disease","volume":"34","author":"Ueland","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1550-2783-6-7","article-title":"Effect of betaine supplementation on power performance and fatigue","volume":"6","author":"Hoffman","year":"2009","journal-title":"J. Int. Soc. Sports Nutr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/RCT.0b013e318168f735","article-title":"Muscle metabolism in Duchenne muscular dystrophy assessed by in vivo proton magnetic resonance spectroscopy","volume":"33","author":"Hsieh","year":"2009","journal-title":"J. Comput. Assist. Tomogr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.clindermatol.2008.01.002","article-title":"The multifunctional role of ectoine as a natural cell protectant","volume":"26","author":"Graf","year":"2008","journal-title":"Clin. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.redox.2016.08.016","article-title":"Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden retriever muscular dystrophy dog model for Duchenne muscular dystrophy","volume":"9","author":"Terrill","year":"2016","journal-title":"Redox Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.biocel.2013.07.009","article-title":"Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice","volume":"45","author":"Terrill","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/B:NERE.0000010438.40376.c9","article-title":"Role of the liver in regulation of body cysteine and taurine levels: A brief review","volume":"29","author":"Stipanuk","year":"2004","journal-title":"Neurochem. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Barbiera, A., Sorrentino, S., Lepore, E., Carf\u00ec, A., Sica, G., Dobrowolny, G., and Scicchitano, B.M. (2020). Taurine attenuates catabolic processes related to the onset of sarcopenia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228865"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.bbagrm.2010.05.004","article-title":"Inhibiting NF-\u03baB activation by small molecules as a therapeutic strategy","volume":"1799","author":"Gupta","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1242\/dmm.018424","article-title":"Animal models of Duchenne muscular dystrophy: From basic mechanisms to gene therapy","volume":"8","author":"McGreevy","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1096\/fj.201802488R","article-title":"Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy","volume":"33","author":"Putten","year":"2019","journal-title":"FASEB J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jacbts.2021.11.004","article-title":"Cardiovascular disease in Duchenne muscular dystrophy: Overview and insight into novel therapeutic targets","volume":"7","author":"Schultz","year":"2022","journal-title":"JACC Basic. Transl. Sci."},{"key":"ref_34","first-page":"2148250","article-title":"Transport of Ca2+ and Ca2+-dependent permeability transition in heart mitochondria in the early stages of Duchenne muscular dystrophy","volume":"10","author":"Dubinin","year":"2020","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1007\/s00726-016-2292-2","article-title":"The effect of taurine and \u03b2-alanine supplementation on taurine transporter protein and fatigue resistance in skeletal muscle from mdx mice","volume":"48","author":"Horvath","year":"2016","journal-title":"Amino Acids"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/mus.20425","article-title":"Systemic administration of L-arginine benefits mdx skeletal muscle function","volume":"32","author":"Barton","year":"2005","journal-title":"Muscle Nerve"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nbd.2005.02.010","article-title":"L-arginine improves dystrophic phenotype in mdx mice","volume":"20","author":"Voisin","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2353\/ajpath.2008.071009","article-title":"L-arginine decreases inflammation and modulates the nuclear factor-kappaB\/matrix metalloproteinase cascade in mdx muscle fibers","volume":"172","author":"Hnia","year":"2008","journal-title":"Am. J. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1096\/fj.05-4821fje","article-title":"Persistent and improved functional gain in mdx dystrophic mice after treatment with L-arginine and deflazacort","volume":"20","author":"Archer","year":"2006","journal-title":"FASEB J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1096\/fba.2020-00104","article-title":"Early administration of L-arginine in mdx neonatal mice delays the onset of muscular dystrophy in tibialis anterior (TA) muscle","volume":"3","author":"Dudley","year":"2021","journal-title":"FASEB Bioadv."},{"key":"ref_41","first-page":"519","article-title":"The effect of L-carnitine supplementation on the dystrophic muscle and exercise tolerance of muscular dystrophy (mdx) mice","volume":"23","author":"Oh","year":"2005","journal-title":"J. Korean Neurol. Assoc."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/j.nmd.2022.07.360","article-title":"VP.86 Effect of a chronic treatment with L-citrulline on funtional, histological and molecular readouts of dystrophic mdx mouse model","volume":"32","author":"Tulimiero","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Merckx, C., Zsch\u00fcntzsch, J., Meyer, S., Raedt, R., Verschuere, H., Schmidt, J., De Paepe, B., and De Bleecker, J.L. (2022). Exploring the therapeutic potential of ectoine in Duchenne muscular dystrophy: Comparison with taurine, a supplement with known beneficial effects in the mdx mouse. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179567"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1203\/PDR.0b013e318163a259","article-title":"l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice","volume":"63","author":"Mok","year":"2008","journal-title":"Pediatr. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"12982","DOI":"10.1038\/s41598-019-49140-x","article-title":"Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin\/utrophin null mice","volume":"9","author":"Ham","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1113\/jphysiol.2007.148338","article-title":"N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice","volume":"586","author":"Whitehead","year":"2008","journal-title":"J. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.nmd.2011.11.007","article-title":"N-Acetylcysteine treatment of dystrophic mdx mice results in protein thiol modifications and inhibition of exercise induced myofibre necrosis","volume":"22","author":"Terrill","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clnu.2012.06.001","article-title":"N-acetylcysteine treatment reduces TNF-\u03b1 levels and myonecrosis in diaphragm muscle of mdx mice","volume":"32","author":"Ferretti","year":"2013","journal-title":"Clin. Nutr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1113\/JP274229","article-title":"Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy","volume":"595","author":"Pinniger","year":"2017","journal-title":"J. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Burns, D.P., Drummond, S.E., Bolger, D., Coiscaud, A., Murphy, K.H., Edge, D., and O\u2019Halloran, K.D. (2019). N-acetylcysteine decreases fibrosis and increases force-generating capacity of mdx diaphragm. Antioxidants, 8.","DOI":"10.3390\/antiox8120581"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1109587","DOI":"10.3389\/fphys.2023.1109587","article-title":"Six weeks of N-acetylcysteine antioxidant in drinking water decreases pathological fiber branching in mdx mouse dystrophic fast-twitch skeletal muscle","volume":"14","author":"Redwan","year":"2023","journal-title":"Front. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1113\/JP271418","article-title":"Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy","volume":"594","author":"Terrill","year":"2016","journal-title":"J. Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/jpet.102.041343","article-title":"Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1","volume":"304","author":"Pierno","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.phrs.2016.02.016","article-title":"Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: A comparison with the gold standard, \u03b1-methyl prednisolone","volume":"106","author":"Capogrosso","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Terrill, J.R., Pinniger, G.J., Nair, K.V., Grounds, M.D., and Arthur, P.G. (2017). Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187317"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Barker, R.G., van der Poel, C., Horvath, D., and Murphy, R.M. (2018). Taurine and methylprednisolone administration at close proximity to the onset of muscle degeneration is ineffective at attenuating force loss in the hind-limb of 28 days mdx mice. Sports, 6.","DOI":"10.3390\/sports6040109"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"14659","DOI":"10.1038\/s41598-018-32613-w","article-title":"Supplementation with a selective amino acid formula ameliorates muscular dystrophy in mdx mice","volume":"8","author":"Banfi","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"H1969","DOI":"10.1152\/ajpheart.00489.2007","article-title":"The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice","volume":"293","author":"Williams","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12986-018-0271-1","article-title":"Branched-chain amino acids in health and disease: Metabolism, alterations in blood plasma, and as supplements","volume":"15","year":"2018","journal-title":"Nutr. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"656604","DOI":"10.3389\/fcell.2021.656604","article-title":"Amino Acid Trafficking and Skeletal Muscle Protein Synthesis: A Case of Supply and Demand","volume":"9","author":"White","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1152\/japplphysiol.00985.2016","article-title":"Interventional strategies to combat muscle disuse atrophy in humans: Focus on neuromuscular electrical stimulation and dietary protein","volume":"125","author":"Dirks","year":"2018","journal-title":"J. Appl. Physiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"105798","DOI":"10.1016\/j.phrs.2021.105798","article-title":"BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: Preclinical evaluation in a murine model of hind limb unloading","volume":"171","author":"Mantuano","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_63","first-page":"CD003725","article-title":"Corticosteroids for the treatment of Duchenne muscular dystrophy","volume":"5","author":"Matthews","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.2337\/db20-0489","article-title":"Manipulation of dietary amino acids prevents and reverses obesity in mice through multiple mechanisms that modulate energy homeostasis","volume":"69","author":"Ruocco","year":"2020","journal-title":"Diabetes"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Okekunle, A.P., Lee, H., Provido, S.M.P., Chung, G.H., Hong, S., Yu, S.H., Lee, C.B., and Lee, J.E. (2022). Dietary branched-chain amino acids and odds of obesity among immigrant Filipino women: The Filipino women\u2019s diet and health study (FiLWHEL). BMC Public Health, 22.","DOI":"10.1186\/s12889-022-12863-0"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"De Bandt, J.P., Coumoul, X., and Barouki, R. (2023). Branched-chain amino acids and insulin resistance, from protein supply to diet-induced obesity. Nutrients, 15.","DOI":"10.3390\/nu15010068"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/oby.23394","article-title":"Branched-chain amino acid supplementation impairs insulin sensitivity and promotes lipogenesis during exercise in diet-induced obese mice","volume":"30","author":"Zhang","year":"2022","journal-title":"Obesity"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jn\/nxaa414","article-title":"Branched-chain amino acid supplementation does not preserve lean mass or affect metabolic profile in adults with overweight or obesity in a randomized controlled weight loss intervention","volume":"151","author":"Ooi","year":"2021","journal-title":"J. Nutr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1359\/jbmr.2002.17.7.1264","article-title":"Dietary essential amino acid supplements increase bone strength by influencing bone mass and bone microarchitecture in ovariectomized adult rats fed an isocaloric low-protein diet","volume":"17","author":"Ammann","year":"2002","journal-title":"J. Bone Min. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11306-022-01919-2","article-title":"Association of amino acid metabolites with osteoporosis, a metabolomic approach: Bushehr elderly health program","volume":"18","author":"Panahi","year":"2022","journal-title":"Metabolomics"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"115082","DOI":"10.1016\/j.bone.2019.115082","article-title":"Circulating amino acids are associated with bone mineral density decline and ten-year major osteoporotic fracture risk in older community-dwelling adults","volume":"129","author":"Su","year":"2019","journal-title":"Bone"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Lv, Z., Shi, W., and Zhang, Q. (2022). Role of essential amino acids in age-induced bone loss. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911281"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/nat.2017.0682","article-title":"Development of exon skipping therapies for Duchenne muscular dystrophy: A critical review and a perspective on the outstanding Issues","volume":"27","author":"Straub","year":"2017","journal-title":"Nucleic Acid. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s40265-016-0657-1","article-title":"Eteplirsen: First Global Approval","volume":"76","author":"Syed","year":"2016","journal-title":"Drugs"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40265-020-01267-2","article-title":"Golodirsen: First approval","volume":"80","author":"Heo","year":"2020","journal-title":"Drugs"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40265-020-01339-3","article-title":"Viltolarsen: First approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s40265-021-01512-2","article-title":"Casimersen: First approval","volume":"81","author":"Shirley","year":"2021","journal-title":"Drugs"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.ymthe.2020.03.003","article-title":"Glycine enhances satellite cell proliferation, cell transplantation, and oligonucleotide efficacy in dystrophic muscle","volume":"28","author":"Lin","year":"2020","journal-title":"Mol. Ther."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-0716-2772-3_10","article-title":"Use of glycine to augment exon skipping and cell therapies for Duchenne muscular dystrophy","volume":"2587","author":"Han","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.3233\/JND-210678","article-title":"Gene therapy for Duchenne muscular dystrophy","volume":"8","author":"Elangkovan","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_81","first-page":"29","article-title":"Side effects of amino acid supplements","volume":"71","year":"2022","journal-title":"Physiol. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40264-020-01026-y","article-title":"Safety of N-acetylcysteine at high doses in chronic respiratory diseases: A review","volume":"44","author":"Calverley","year":"2021","journal-title":"Drug Saf."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5056\/jnm19029","article-title":"Spatiotemporal mapping reveals regional gastrointestinal dysfunction in mdx dystrophic mice ameliorated by oral L-arginine supplementation","volume":"26","author":"Swiderski","year":"2020","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/ajcn\/83.4.823","article-title":"Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy","volume":"83","author":"Mok","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Mok, E., Letellier, G., Cuisset, J.M., Denjean, A., Gottrand, F., Alberti, C., and Hankard, R. (2009). Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: A randomized crossover trial. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005448"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.mri.2010.03.008","article-title":"Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: A randomized, placebo-controlled 31P MRS study","volume":"28","author":"Banerjee","year":"2010","journal-title":"Magn. Reson. Imaging"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ana.20523","article-title":"CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy","volume":"58","author":"Escolar","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e1914171","DOI":"10.1001\/jamanetworkopen.2019.14171","article-title":"Effect of combination L-Citrulline and metformin treatment on motor function in patients with Duchenne muscular dystrophy: A randomized clinical trial","volume":"2","author":"Hafner","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e1434","DOI":"10.1212\/WNL.0000000000008872","article-title":"Randomized controlled trial of N-acetylcysteine therapy for RYR1-related myopathies","volume":"94","author":"Todd","year":"2020","journal-title":"Neurology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12986-022-00684-2","article-title":"Protective and therapeutic effectiveness of taurine supplementation plus low calorie diet on metabolic parameters and endothelial markers in patients with diabetes mellitus: A randomized, clinical trial","volume":"19","author":"Moludi","year":"2022","journal-title":"Nutr. Metab."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jnnp-2018-317964","article-title":"Taurine supplementation for prevention of stroke-like episodes in MELAS: A multicentre, open-label, 52-week phase III trial","volume":"90","author":"Ohsawa","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/apt.14950","article-title":"Randomised clinical trial: Oral taurine supplementation versus placebo reduces muscle cramps in patients with chronic liver disease","volume":"48","author":"Vidot","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12970-021-00438-0","article-title":"Taurine in sports and exercise","volume":"18","author":"Kurtz","year":"2021","journal-title":"J. Int. Soc. Sports Nutr."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2478\/bhk-2023-0010","article-title":"Effects of acute taurine consumption on single bout of muscular endurance resistance exercise performance and recovery in resistance trained young male adults","volume":"15","author":"Akalp","year":"2023","journal-title":"Biomed. Hum. Kinet."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s40279-018-0896-2","article-title":"The effects of an oral taurine dose and supplementation period on endurance exercise performance in humans: A meta-analysis","volume":"48","author":"Waldron","year":"2018","journal-title":"Sports Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"eabn9257","DOI":"10.1126\/science.abn9257","article-title":"Taurine deficiency as a driver of aging","volume":"380","author":"Singh","year":"2023","journal-title":"Science"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2147\/DDDT.S110163","article-title":"Anti-inflammatory drugs for Duchenne muscular dystrophy: Focus on skeletal muscle-releasing factors","volume":"10","author":"Miyatake","year":"2016","journal-title":"Drug Des. Devel Ther."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000525045","article-title":"Antioxidants for treatment of duchenne muscular dystrophy: A systematic review and meta-analysis","volume":"85","author":"Ren","year":"2022","journal-title":"Eur. Neurol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"102332","DOI":"10.1016\/j.coph.2022.102332","article-title":"Update on anti-fibrotic pharmacotherapies in skeletal muscle disease","volume":"68","author":"Muraine","year":"2023","journal-title":"Curr. Opin. Pharmacol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/7\/2033\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:14:59Z","timestamp":1760127299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/7\/2033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,19]]},"references-count":99,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["biomedicines11072033"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines11072033","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,19]]}}}